Researcher Profile Statistics: Baptista, Salete
Geo Map
Region
#
NA - North America
40
EU - Europe
30
AS - Asia, other
16
AF - Africa
3
Unknown
2
Total
91
Country
#
US - United States of America
40
PT - Portugal
17
CN - China
12
IE - Ireland
10
MA - Morocco
3
IN - India
2
DE - Germany
1
ES - Spain
1
ID - Indonesia
1
NL - Netherlands
1
other - Other Country
3
Total
91
City
#
Dublin
10
New York
8
Inglewood
7
Ashburn
5
Rabat
3
Coimbra
2
Amsterdam
1
Anadia
1
Baton Rouge
1
Delhi
1
other
52
Total
91
Most viewed items
#
ID: 58783 - Combining Virtual Screening Protocol and In Vitro Evaluation towards the Discovery of BACE1 Inhibitors
91
Total
91
Most type viewed
#
ID: all -
91
ID: other -
0
ID: journal -
0
ID: conference -
0
ID: book -
0
ID: thesis -
0
ID: selected -
0
Total
91
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2023
0 0
13 0 0 1
0 0 1 3
5 18
41
2024
10 8
4 11 11 1
5 0 0 0
0 0
50
Ever
91
Geo Map
Region | # |
---|---|
NA - North America | 40 |
EU - Europe | 30 |
AS - Asia, other | 16 |
AF - Africa | 3 |
Unknown | 2 |
Total | 91 |
Country | # |
---|---|
US - United States of America | 40 |
PT - Portugal | 17 |
CN - China | 12 |
IE - Ireland | 10 |
MA - Morocco | 3 |
IN - India | 2 |
DE - Germany | 1 |
ES - Spain | 1 |
ID - Indonesia | 1 |
NL - Netherlands | 1 |
other - Other Country | 3 |
Total | 91 |
City | # |
---|---|
Dublin | 10 |
New York | 8 |
Inglewood | 7 |
Ashburn | 5 |
Rabat | 3 |
Coimbra | 2 |
Amsterdam | 1 |
Anadia | 1 |
Baton Rouge | 1 |
Delhi | 1 |
other | 52 |
Total | 91 |
Most viewed items | # |
---|---|
ID: 58783 - Combining Virtual Screening Protocol and In Vitro Evaluation towards the Discovery of BACE1 Inhibitors | 91 |
Total | 91 |
Most type viewed | # |
---|---|
ID: all - | 91 |
ID: other - | 0 |
ID: journal - | 0 |
ID: conference - | 0 |
ID: book - | 0 |
ID: thesis - | 0 |
ID: selected - | 0 |
Total | 91 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 | 0 | 0 | 13 | 0 | 0 | 1 | 0 | 0 | 1 | 3 | 5 | 18 | 41 |
2024 | 10 | 8 | 4 | 11 | 11 | 1 | 5 | 0 | 0 | 0 | 0 | 0 | 50 |
Ever | 91 |